Skip to main content

and
  1. No Access

    Article

    Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel

    Large prospective studies of chemotherapy for metastatic or recurrent adenoid cystic carcinoma (ACC) of the head and neck are lacking due to the rarity of ACC. The aim of this study is to evaluate the efficacy...

    Naoki Fukuda, Yu Fujiwara, **aofei Wang in European Archives of Oto-Rhino-Laryngology (2021)